CLOVIS ONCOLOGY INC's ticker is and the CUSIP is 189464AB6. A total of 31 filers reported holding CLOVIS ONCOLOGY INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.3%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 49,064,000 | $47,809,000 | 0.85% |
| United Asset Strategies, Inc. | 1,950,000 | $1,915,000 | 0.26% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 6,772,000 | $6,637,000 | 0.18% |
| PALISADE CAPITAL MANAGEMENT, LP | 1,629,000 | $1,596,000 | 0.04% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 1,000,000 | $998,000,000 | 0.01% |
| D. E. Shaw & Co., Inc. | 3,380,000 | $3,321,000 | 0.00% |
| MACKAY SHIELDS LLC | 110,000 | $110,000 | 0.00% |
| UBS Group AG | 3,000 | $3,000 | 0.00% |
| Advisory Services Network, LLC | 2,000 | $2,000 | 0.00% |
| CITIGROUP INC | 10,000 | $10,000 | 0.00% |